How has Emergent Biosolutions's warrants and rights outstanding changed year-over-year?

Emergent Biosolutions's warrants and rights outstanding decreased by 0.0% year-over-year, from 2.5M to 2.5M.

Emergent Biosolutions EBS Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Nuvation BioNUVB

5.8M0.0%

KEE

Keel Infrastructure Corp. Common StockKEEL

2.2M—

Unusual MachinesUMAC

0-100%

KRAKacquisition KRAQ

0—

The RealRealREAL

7.9M—

NuScale PowerSMR

0-100%

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's warrants and rights outstanding?: Emergent Biosolutions (EBS) reported warrants and rights outstanding of 2.5M in Q1 2026.
How has Emergent Biosolutions's warrants and rights outstanding changed year-over-year?: Emergent Biosolutions's warrants and rights outstanding decreased by 0.0% year-over-year, from 2.5M to 2.5M.